During the past decade, CCOP - Montana Cancer Consortium conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 216 clinical trials were completed, i.e. on average, 1440% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 56 clinical trials were completed. i.e. 2800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Montana Cancer Consortium" #1 sponsor was "SWOG Cancer Research Network" with 161 trials, followed by "National Cancer Institute (NCI)" with 92 trials sponsored, "Alliance for Clinical Trials in Oncology" with 83 trials sponsored, "Radiation Therapy Oncology Group" with 51 trials sponsored and "Gynecologic Oncology Group" with 51 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Montana Cancer Consortium" #1 collaborator was "National Cancer Institute (NCI)" with 369 trials as a collaborator, "Cancer and Leukemia Group B" with 28 trials as a collaborator, "SWOG Cancer Research Network" with 28 trials as a collaborator, "Eastern Cooperative Oncology Group" with 27 trials as a collaborator and "NCIC Clinical Trials Group" with 24 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Montana Cancer Consortium" are "Breast Cancer" (66 trials), "Lung Cancer" (44 trials), "Lymphoma" (28 trials), "Prostate Cancer" (26 trials) and "Leukemia" (25 trials). Many other conditions were trialed in "CCOP - Montana Cancer Consortium" in a lesser frequency.

Most popular intervention types in "CCOP - Montana Cancer Consortium" are "Drug" (400 trials), "Other" (147 trials), "Biological" (138 trials), "Radiation" (107 trials) and "Procedure" (70 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "radiation therapy" (67 trials), "placebo" (41 trials), "paclitaxel" (38 trials) and "cisplatin" (37 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Montana Cancer Consortium" are 337 trials for "All" genders, 103 trials for "Female" genders and 29 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Montana Cancer Consortium". undefined are not yet recruiting, undefined are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 340 completed trials in CCOP - Montana Cancer Consortium, undefined suspended trials, and 55 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Montana Cancer Consortium, 27 "Phase 1" clinical trials were conducted, 230 "Phase 2" clinical trials and 205 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".